NAUTILUS BIOTECHNOLOGY INC's ticker is and the CUSIP is 63909J908. A total of 3 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 100 | -96.0% | 0.00% | – |
| Q3 2022 | $5,000 | -81.5% | 2,500 | -75.7% | 0.00% | – |
| Q2 2022 | $27,000 | +107.7% | 10,300 | +221.9% | 0.00% | – |
| Q1 2022 | $13,000 | +30.0% | 3,200 | +60.0% | 0.00% | – |
| Q4 2021 | $10,000 | -33.3% | 2,000 | +33.3% | 0.00% | – |
| Q3 2021 | $15,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2021 | $15,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,000 | $4,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,500 | $5,000 | 0.00% |